Open AccessHigh efficacy of switching to bictegravir/emtricitabine/tenofovir alafenamide in people with suppressed HIV and preexisting M184V/I
Author(s) -
Paul E. Sax,
Kristen Andreatta,
JeanMichel Molina,
Eric S. Daar,
Debbie Hagins,
Rima Acosta,
Michelle L D’Antoni,
Silvia Chang,
Ross Martin,
Hui Liu,
Christiana Blair,
Ian R. McNicholl,
Joel E. Gallant,
Sean E Collins,
Hal Martin,
Kirsten White
Publication year - 2022
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000003244
Subject(s) - resistance mutation , emtricitabine , tenofovir alafenamide , medicine , virology , genotype , viral load , human immunodeficiency virus (hiv) , biology , antiretroviral therapy , genetics , polymerase chain reaction , reverse transcriptase , gene